Reference
Yang Z, et al. Acquired EGFR L718V Mutation as the Mechanism for Osimertinib Resistance in a T790M-Negative Non-Small-Cell Lung Cancer Patient. Targeted Oncology 14: 369-374, No. 4, Aug 2019. Available from: URL: http://doi.org/10.1007/s11523-019-00652-6 - China
Rights and permissions
About this article
Cite this article
Osimertinib. Reactions Weekly 1769, 336 (2019). https://doi.org/10.1007/s40278-019-67350-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-67350-x